[1] | Qi QI, Xin YAO, Guodong YANG, Jianping QIN. Research advances in the influence of intraoperative factors during transjugular intrahepatic portosystemic shunt on the development of hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2023, 39(8): 1966-1971. doi: 10.3969/j.issn.1001-5256.2023.08.030 |
[2] | Menghao LI, Kai LI, Shihao TANG, Zhengyu WANG, Wengang GUO, Zhanxin YIN, Guohong HAN. Changes in gut microbiota after transjugular intrahepatic portosystemic shunt in cirrhotic patients with mild hepatic encephalopathy in different prognosis groups[J]. Journal of Clinical Hepatology, 2021, 37(2): 326-330. doi: 10.3969/j.issn.1001-5256.2021.02.016 |
[3] | Junjun ZHANG, Xin GAO, Ying WU, Yi CHENG, Weitian XU. A case of congenital intrahepatic portosystemic venous shunt with hepatic encephalopathy in the elderly[J]. Journal of Clinical Hepatology, 2021, 37(6): 1421-1424. doi: 10.3969/j.issn.1001-5256.2021.06.040 |
[4] | Gonghai CHEN, Guangchuan WANG, Chunqing ZHANG. Current status of research on hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2021, 37(5): 1201-1204. doi: 10.3969/j.issn.1001-5256.2021.05.047 |
[5] | Shuaijie QIAN, Hao WU. Hepatic encephalopathy: Modern views on the treatment of abnormal portosystemic shunt[J]. Journal of Clinical Hepatology, 2021, 37(12): 2774-2777. doi: 10.3969/j.issn.1001-5256.2021.12.007 |
[6] | Wang Zhong, Yue ZhenDong, Zhao HongWei, Wang Lei, Fan ZhenHua, Wu YiFan, Dong ChengBin, Zhang Yu, Liu FuQuan. Value of indocyanine green retention rate at 15 minutes in predicting the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in liver cancer patients with portal hypertension[J]. Journal of Clinical Hepatology, 2020, 36(9): 1994-1997. doi: 10.3969/j.issn.1001-5256.2020.09.017 |
[7] | Yao YunHai, Luo Yan, Zhu JingLe, Gan JianHe, Zhao WeiFeng. Risk factors for hepatic encephalopathy after emergency transjugular intrahepatic portosystemic shunt for patients with acute esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2020, 36(2): 343-347. doi: 10.3969/j.issn.1001-5256.2020.02.022 |
[8] | Li Jing, Jiang Yong, Zhang Xu. Efficacy of transjugular intrahepatic portosystemic shunt versus endoscopic cyanoacrylate injection in treatment of gastric variceal bleeding: A meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(2): 349-353. doi: 10.3969/j.issn.1001-5256.2019.02.021 |
[9] | He ChuangYe, Chen Hui, Lyu Yong, Xia DongDong, Yu TianLei, Yuan XuLong, Li Kai, Wang ZhengYu, Niu Jing, Bai Wei, Guo WenGang, Tie Jun, Yin ZhanXin, Han GuoHong. Safety and efficacy of flow-reducing stent in treatment of recurrent or persistent hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2019, 35(8): 1719-1722. doi: 10.3969/j.issn.1001-5256.2019.08.014 |
[10] | Hu WenYan, Rao ChunYan, Liu HuaBao, Wang YaNan. A case of spontaneous portosystemic shunt with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2019, 35(3): 611-612. doi: 10.3969/j.issn.1001-5256.2019.03.033 |
[11] | Wang Zhong, Liu FuQuan. Research advances in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2019, 35(12): 2824-2827. doi: 10.3969/j.issn.1001-5256.2019.12.040 |
[12] | He HaiGuan, Shen YiNan, Pang ShuJie, Yang Tian, Lu JunHua. Short-term efficacy of splenectomy versus partial splenic embolization for liver cirrhosis and hypersplenism: a Meta-analysis[J]. Journal of Clinical Hepatology, 2016, 32(2): 301-306. doi: 10.3969/j.issn.1001-5256.2016.02.021 |
[13] | Liu TieJun. Therapeutic effect and advantages of percutaneous transhepatic variceal embolization in treatment of variceal rupture and bleeding after devascularization: an analysis of 34 cases[J]. Journal of Clinical Hepatology, 2015, 31(11): 1867-1869. doi: 10.3969/j.issn.1001-5256.2015.11.023 |
[14] | Zhao Kai, Zhang YueXin. Treatment of minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2014, 30(10): 1094-1096. doi: 10.3969/j.issn.1001-5256.2014.10.030 |
[15] | Bian Ce, Wang ZhongHao, Li Zhen, Li ChunMin. Severe Budd-Chiari syndrome with 18 years patency after mesojugular shunt (case report)[J]. Journal of Clinical Hepatology, 2011, 27(2): 199-200. |
[16] | Wang ZhongHao, Li ChunMin. Mesocavoatrial shunt healing of type Ⅱ Budd-Chiari syndrome:a case report[J]. Journal of Clinical Hepatology, 2011, 27(2): 196-197. |
[17] | Xu DaHai, Zhang Nan, Gao JinYing, Wu Yang. The therapeutic development of hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2011, 27(2): 218-221. |
[18] | Jiang Hao, Xie Qing. Advances in the diagnosis and treatment of hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2011, 27(10): 1027-1031. |
[19] | Wang YuMing, Yan ZeHui. The new concepts on hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2010, 26(6): 568-574. |
[20] | Cheng ChangSheng. The effect of PTVE in patients suffering from upper gastrointestinal bleeding[J]. Journal of Clinical Hepatology, 2010, 26(5): 551-552. |